معرفی
Dr. Mercedeh Arasta is affiliated with Newcastle University as a researcher, focusing on pharmacological and biochemical innovations in drug discovery. Her work intersects molecular biology and targeted therapy, particularly in kinase inhibition and cancer signaling pathways.
Her research includes the 2019 publication on a novel ERK5 inhibitor, highlighting contributions to understanding kinase selectivity over p38α and BRD4. This work aligns with advancements in developing orally bioavailable therapies for cancer and related diseases.
The article above reflects her expertise in
- Biochemistry
- Pharmacology
- Molecular cancer research
- Drug development
۰مقاله منتشرشده